OART is increasingly emerging to assess and adapt treatment for cancer patients
Category: News
The rare neurodevelopmental condition CDKL5 is characterised by early-onset epilepsy
The cell could be a target for new immunotherapies for the chronic disease
The committee has advised that the vaccine should be given to those at the highest risk
The new products are in the areas of gastrointestinal and respiratory medicines
The HTA reported that Brainomix 360 improved access to treatment for stroke patients
The biodegradable polymer scaffold encourages the body to grow new tissue
Hypoxic-ischaemic encephalopathy affects around three million babies worldwide every year
The neurodegenerative condition currently affects over 944,000 people in the UK
The aggressive brain cancer is responsible for over 3,000 cases in the UK every year